• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2011 Fiscal Year Final Research Report

Intrahepatic microRNA expression and response to peginterferon-α and ribavirin therapy in patients with chronic hepatitis C

Research Project

  • PDF
Project/Area Number 21590856
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Gastroenterology
Research InstitutionOsaka City University

Principal Investigator

ENOMOTO Masaru  大阪市立大学, 大学院・医学研究科, 准教授 (20423874)

Co-Investigator(Kenkyū-buntansha) KAWADA Norifumi  大阪市立大学, 大学院・医学研究科, 教授 (30271191)
TAMORI Akihiro  大阪市立大学, 大学院・医学研究科, 准教授 (30291595)
Project Period (FY) 2009 – 2011
KeywordsC型慢性肝炎 / マイクロRNA / インターフェロン / リバビリン
Research Abstract

The regulated microRNAs(miRNAs) in human livers infected with hepatitis C virus(HCV) were identified by microarray analysis. MiR-422a was down-regulated, and miR-199a-5p/199a-3p and miR-221/222 up-regulated in the human liver in a fibrosis progression-dependent manner. Their expression was validated by real-time RT-PCR. Among these miRNAs, miR-222 increased in mouse livers from two fibrosis models. The expression of miR-222 was up-regulated in cultured stellate cells LX-2 and increased during the course of culture-dependent activation of mouse primary stellate cells. NF-κB inhibitor significantly suppressed the miR-222 induction that was stimulated in culture by TNF-α or TGF-α. Although over-expression or down-regulation of miR-222 failed to regulate the growth of LX-2 cells, miR-222 bound to the p27^<Kip1> 3'UTR and regulated the expression of the corresponding protein. Transient transfection with miR-222 precursors significantly up-regulated α1(I) collagen and down-regulated MMP-1 mRNA expressions. In conclusion, miR-222 may be new markers for stellate cell activation and liver fibrosis progression.

  • Research Products

    (12 results)

All 2012 2011 2010 2009 Other

All Journal Article (5 results) (of which Peer Reviewed: 5 results) Presentation (5 results) Remarks (1 results) Patent(Industrial Property Rights) (1 results)

  • [Journal Article] MicroRNA-221/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis2012

    • Author(s)
      Ogawa T, Enomoto M, Fujii H, Sekiya Y, Yoshizato K, Ikeda K, Kawada N
    • Journal Title

      Gut

      Volume: (in press)

    • Peer Reviewed
  • [Journal Article] Could trastuzumab suppress hepatitis C virus in a patient with chronic hepatitis and breast cancer?2011

    • Author(s)
      Tamori A, Kawajiri H, Takashima T, Motoyama H, Morikawa H, Enomoto M, Hirakawa K, Kawada N
    • Journal Title

      Am J Gastroenterol

      Volume: 106 Pages: 1865-6

    • Peer Reviewed
  • [Journal Article] Favorable factors for re-treatment with pegylated interferon α2a plus ribavirin in patients with high viral loads of genotype 1 hepatitis C virus2011

    • Author(s)
      Tamori A, Kioka K, Kurai O, Sakaguchi H, Enomoto M, Fujii H, Kobayashi S, Iwai S, Morikawa H, Yamaguchi S, Kawasaki Y, Oka H, Tanaka Y, Kawada N
    • Journal Title

      Hepatol Res

      Volume: 41 Pages: 1169-77

    • Peer Reviewed
  • [Journal Article] Real-time tissue elastography as a tool for the noninvasive assessment of liver stiffness in patients with chronic hepatitis C2011

    • Author(s)
      Morikawa H, Fukuda K, Kobayashi S, Fujii H, Iwai S, Enomoto M, Tamori A, Sakaguchi H, Kawada N
    • Journal Title

      J Gastroenterol

      Volume: 46 Pages: 350-8

    • Peer Reviewed
  • [Journal Article] Emerging antiviral drugs for hepatitis C virus2009

    • Author(s)
      Enomoto M, Tamori A, Kawada N
    • Journal Title

      Rev Recent Clin Trials

      Volume: 4 Pages: 179-84

    • Peer Reviewed
  • [Presentation] 慢性肝疾患における肝線維化バイオマーカーとしてのマイクロRNAの有用性2011

    • Author(s)
      榎本大、小川智弘、河田則文
    • Organizer
      第39回日本肝臓学会西部会
    • Place of Presentation
      岡山
    • Year and Date
      20111209-10
  • [Presentation] Indication of the Activation of Stellate Cells and the Progression of Liver Fibrosis by MicroRNA-2222011

    • Author(s)
      Enomoto M, Ogawa T, Iizuka M, Fujii H, Tamori A, Yoshizato K, Ikeda K, Kawada N
    • Organizer
      62^<nd> Annual Meeting of the American Association for the Study of Liver Diseases(AASLD)
    • Place of Presentation
      San Francisco, CA
    • Year and Date
      20111104-08
  • [Presentation] 肝線維化と星細胞活性化に関与するマイクロRNAの解析2011

    • Author(s)
      飯塚昌司、小川智弘、関谷由美子、榎本大、吉里勝利、池田一雄、河田則文
    • Organizer
      第15回日本肝臓学会大会
    • Place of Presentation
      福岡
    • Year and Date
      20111020-21
  • [Presentation] 慢性肝疾患における肝線維化診断マーカーとしてのmiR-222の有用性2011

    • Author(s)
      飯塚昌司、榎本大、小川智弘、藤井英樹、小林佐和子、岩井秀司、森川浩安、田守昭博、河田則文
    • Organizer
      第15回日本肝臓学会大会
    • Place of Presentation
      福岡
    • Year and Date
      20111020-21
  • [Presentation] C型慢性肝炎患者における肝線維化診断マーカーとしてのマイクロRNAの有用性2011

    • Author(s)
      小川智弘、榎本大、河田則文
    • Organizer
      第97回日本消化器病学会総会
    • Place of Presentation
      東京
    • Year and Date
      20110513-15
  • [Remarks]

    • URL

      http://www.med.osaka-cu.ac.jp/syoukaki/hepatology/index.html

  • [Patent(Industrial Property Rights)] 肝線維症の存在及び/又は肝線維症の重症度の判定方法、判定マーカー、判定用キット、肝線維症の治療の効果予測方法、効果予測マーカー、並びに効果予測用キット2010

    • Inventor(s)
      河田則文、榎本大、小川智弘
    • Industrial Property Rights Holder
      公立大学法人大阪市立大学
    • Industrial Property Number
      IPD0111、特願2010-281254
    • Filing Date
      2010-12-17

URL: 

Published: 2013-07-31  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi